CDK2 and cancer: Thereby, these studies in general provide prime examples of how basic research in molecular cancer biology, cell cycle, progression, and signal transduction can drive translational research and lead to important hypotheses for targeted therapy regarding predictive biomarkers and approaches to overcome resistance like the combination of CDK4/6 with CDK2 or CHK1 inhibition, which now need to be tested further towards the clinic.